StockData
IMMUTEP Ltd logo

IMMUTEP Ltd (IMMP) stock

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.25−0.01 (-0.31%)

Close on Nov 18, 2026Market cap $23.95MP/E –Yield –

Immutep operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

No operating income figures for Immutep

Immutep has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Immutep figures

See a number that looks wrong?